Highlights

  • Medibank Private (ASX:MPL) announced its FY26 results in August 2026.
  • First-half FY26 group revenue from external customers increased 5.5% to AUD 4.50 billion.
  • First-half FY26 group operating profit reached AUD 381.7 million, a 6.0% increase.
  • Medibank reported AUD 6.9 billion in claims paid during FY26 and expanded its healthcare activities.

Medibank Private Limited (ASX:MPL) operates Australian private health insurance brands and healthcare services, including its Medibank and ahm offerings and Amplar Health. The company released its full-year FY26 results in August and has continued developing prevention, primary care and out-of-hospital services. On 21 October 2026, Medibank Private (ASX:MPL) closed at AUD 4.83 per share, up 1.05% for the day. Its recent disclosures describe changes in policyholder participation, claims expenditure and healthcare service delivery.

Company Business

Medibank Private (ASX:MPL) provides resident and non-resident private health insurance and operates healthcare businesses serving patients and other payors. Health insurance income depends on policy participation, premiums, claims and administrative expenditure. Its Medibank Health activities include primary care, prevention programs and clinician-supported services. The group has a nationwide Australian focus, with services delivered through physical clinics and other care channels.

Amplar Health forms part of this broader service strategy. In FY26, Medibank reported support for more than four million general-practitioner consultations through 169 GP and medical clinics. Its Live Better program exceeded one million members, while the group recorded 334,000 enrolments in everyday prevention programs and 36,000 clinician-guided prevention services. These activities sit alongside the insurer’s core obligation to fund eligible treatment and hospital claims.

Recent Development

In August 2026, Medibank Private (ASX:MPL) reported that it supported approximately six million people across its health and wellbeing activities. Its FY26 disclosures recorded AUD 6.9 billion in claims paid and almost AUD 300 million in customer value measures beyond those claims. The company stated that Medibank Health accounted for approximately 12% of group operating profit, indicating a larger contribution from healthcare operations outside traditional insurance.

The group also reported that 57% of Medibank policyholders engaged with its health and wellbeing offerings during FY26. In September 2026, Amplar Health announced a refreshed brand identity. These developments reflect continued investment in service delivery, clinical networks and customer engagement. The reported measures describe enrolments, service use and profit contribution; they are not interchangeable with the number of insured policyholders.

Financial Performance and Sector Context

In the six months ended December 2025, Medibank Private (ASX:MPL) recorded revenue from external customers of AUD 4,503.5 million, compared with AUD 4,270.7 million a year earlier. Group operating profit rose from AUD 360.1 million to AUD 381.7 million. Within that result, health insurance operating profit increased to AUD 361.5 million, while Medibank Health segment profit rose to AUD 48.3 million from AUD 37.6 million.

Underlying first-half net profit after tax was AUD 297.8 million, compared with AUD 298.7 million in the corresponding period. Statutory net profit attributable to shareholders was AUD 302.9 million, against AUD 340.3 million previously. Net investment income declined to AUD 94.9 million from AUD 114.5 million. The figures illustrate the distinction between operating earnings, investment returns and reported profit under the group’s accounting framework.

The first-half fully franked ordinary dividend was 8.3 Australian cents per share, compared with 7.8 cents a year earlier. In the Australian private health insurance market, medical cost inflation, hospital funding arrangements, premiums and consumer affordability remain relevant operating considerations. Medibank’s FY26 reporting highlighted the task of balancing healthcare cost increases with the price and value of insurance cover.

Risks to Consider

For Medibank Private (ASX:MPL), claims inflation and changes in utilisation can affect insurance margins. Competition and affordability pressures may influence policyholder retention and new-member growth. Healthcare acquisitions and expanded clinical networks involve integration, staffing, operating and clinical-quality requirements. Technology security, regulatory compliance and litigation also remain relevant, particularly given the company’s disclosed expenditure on information-security improvements and legal matters.

What to Watch Next

Medibank has scheduled its 2026 annual general meeting for 18 November 2026. Subsequent operating disclosures can clarify resident and non-resident policyholder trends, claims costs and the contribution of Medibank Health. Further information on clinic activity, prevention enrolments and the balance between investment expenditure and service revenue will provide a more complete view of its diversification. The timing and outcome of regulatory and legal processes also remain identifiable matters to monitor.

Key Insights

Medibank Private (ASX:MPL) entered the latter part of 2026 with an insurance business supported by a growing healthcare-services segment. Its first-half financial statements showed higher revenue and operating profit but slightly lower underlying net profit, alongside reduced investment income. FY26 disclosures subsequently recorded substantial claims payments and wider participation in prevention and primary care. Future reporting will clarify how healthcare activities, insurance economics and operating costs develop together.